{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T04:46:26.520291+00:00","published_at":"2026-10-16T04:46:26.520291+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:5qfkr012zx9go","event_type":"CEO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:derek-chang","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:e359aa9adfd484ae58d99eb4dfb63c07024ecaf45119a809aaf1295f1b616d75"],"summary":"Derek Chang executive of Allogene Therapeutics, Inc., effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1peb5qw1jl8yx6","event_type":"GC_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:earl-douglas","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:49f57b56db9669a6e5377a23b131b32c4f33cc0d52bccbd255a548a3fddfd7b9"],"summary":"Earl Douglas executive of Allogene Therapeutics, Inc., effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:d73h3611hk41s","event_type":"CFO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:geoffrey-parker","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:7a8e53f8022fc4e59cc536d4294344629256f3aa587b4d4744b940d9713a75d0"],"summary":"Geoffrey Parker executive of Allogene Therapeutics, Inc., effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18ua8nc1emy8m2","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:stephen-mayo-ph-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Stephen Mayo, Ph.D. seat on Allogene Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vz339b19y2anr","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:elizabeth-barrett","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Elizabeth Barrett seat on Allogene Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:flsnqrd4gzln","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:vicki-sato-ph-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Vicki Sato, Ph.D. seat on Allogene Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dv6aib40m7w9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:elizabeth-barrett","alpha:committee:allogene-therapeutics-inc:audit"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:20"],"evidence_ids":["alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b"],"summary":"Elizabeth Barrett member of Audit, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:773k3hm9c27b","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:david-chang-m-d-ph-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"David Chang, M.D., Ph.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17hkgq61yf540i","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:deborah-messemer","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Deborah Messemer seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y2u1p81lu30qc","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:franz-humer-ph-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Franz Humer, Ph.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1uaimlqq5iy7s","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:john-deyoung","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"John DeYoung seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:huaatwd93t0a","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:owen-witte-m-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Owen Witte, M.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ddbd9ymncqfg","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:todd-sisitsky","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Todd Sisitsky seat on Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:n0ygjg1kdei9q","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:committee:allogene-therapeutics-inc:audit-chair-nominating-and-governance-chair","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Audit · Chair; Nominating and Governance · Chair committee of Allogene Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15a4ikppbqokh","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:deborah-messemer","alpha:committee:allogene-therapeutics-inc:audit-chair-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Deborah Messemer member of Audit · Chair; Nominating and Governance · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sr5ji515l92m5","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:john-deyoung","alpha:committee:allogene-therapeutics-inc:compensation"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:23"],"evidence_ids":["alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b"],"summary":"John DeYoung member of Compensation, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1djwtecbm80f8","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:todd-sisitsky","alpha:committee:allogene-therapeutics-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:25"],"evidence_ids":["alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b"],"summary":"Todd Sisitsky member of Nominating and Governance, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cbx7y58rktoz","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:arie-belldegrun-m-d","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Arie Belldegrun, M.D. seat on Allogene Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ikljrm1uk2urm","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T04:46:26.520291+00:00","subject_ids":["alpha:person:joshua-kazam","alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9"],"caused_claim_ids":["alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890"],"summary":"Joshua Kazam seat on Allogene Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:5","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arie-belldegrun-m-d","object_label":"Arie Belldegrun, M.D.","object_source_name_forms":[],"value":"Arie Belldegrun, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arie-belldegrun-m-d","name":"Arie Belldegrun, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:6","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-chang-m-d-ph-d","object_label":"David Chang, M.D., Ph.D.","object_source_name_forms":[],"value":"David Chang, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-chang-m-d-ph-d","name":"David Chang, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:deborah-messemer","object_label":"Deborah Messemer","object_source_name_forms":[],"value":"Deborah Messemer: Director, Audit · Chair; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:deborah-messemer","name":"Deborah Messemer"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:8","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:elizabeth-barrett","object_label":"Elizabeth Barrett","object_source_name_forms":[],"value":"Elizabeth Barrett: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:elizabeth-barrett","name":"Elizabeth Barrett"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:9","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:franz-humer-ph-d","object_label":"Franz Humer, Ph.D.","object_source_name_forms":[],"value":"Franz Humer, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:franz-humer-ph-d","name":"Franz Humer, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:10","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-deyoung","object_label":"John DeYoung","object_source_name_forms":[],"value":"John DeYoung: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-deyoung","name":"John DeYoung"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:11","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joshua-kazam","object_label":"Joshua Kazam","object_source_name_forms":[],"value":"Joshua Kazam: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joshua-kazam","name":"Joshua Kazam"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:12","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:owen-witte-m-d","object_label":"Owen Witte, M.D.","object_source_name_forms":[],"value":"Owen Witte, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:owen-witte-m-d","name":"Owen Witte, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:13","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephen-mayo-ph-d","object_label":"Stephen Mayo, Ph.D.","object_source_name_forms":[],"value":"Stephen Mayo, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stephen-mayo-ph-d","name":"Stephen Mayo, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:14","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:todd-sisitsky","object_label":"Todd Sisitsky","object_source_name_forms":[],"value":"Todd Sisitsky: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:todd-sisitsky","name":"Todd Sisitsky"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:15","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:vicki-sato-ph-d","object_label":"Vicki Sato, Ph.D.","object_source_name_forms":[],"value":"Vicki Sato, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:vicki-sato-ph-d","name":"Vicki Sato, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:17","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:derek-chang","object_label":"Derek Chang","object_source_name_forms":[],"value":"Derek Chang: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:derek-chang","name":"Derek Chang"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:e359aa9adfd484ae58d99eb4dfb63c07024ecaf45119a809aaf1295f1b616d75","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:55.528673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:18","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:earl-douglas","object_label":"Earl Douglas","object_source_name_forms":[],"value":"Earl Douglas: Senior Vice President, General Counsel and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:earl-douglas","name":"Earl Douglas"},"title":"Senior Vice President, General Counsel and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:49f57b56db9669a6e5377a23b131b32c4f33cc0d52bccbd255a548a3fddfd7b9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:56.363968+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:19","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:geoffrey-parker","object_label":"Geoffrey Parker","object_source_name_forms":[],"value":"Geoffrey Parker: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:geoffrey-parker","name":"Geoffrey Parker"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:document:7a8e53f8022fc4e59cc536d4294344629256f3aa587b4d4744b940d9713a75d0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:55.941207+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:20","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Deborah Messemer; Members Deborah Messemer (Chair); Elizabeth Barrett","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Deborah Messemer","members":[{"display_name":"Deborah Messemer","person_slug":"deborah-messemer","is_chair":true},{"display_name":"Elizabeth Barrett","person_slug":"elizabeth-barrett","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:23","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members John DeYoung","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"John DeYoung","person_slug":"john-deyoung","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:25","subject_id":"alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Deborah Messemer; Members Deborah Messemer (Chair); Todd Sisitsky","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Deborah Messemer","members":[{"display_name":"Deborah Messemer","person_slug":"deborah-messemer","is_chair":true},{"display_name":"Todd Sisitsky","person_slug":"todd-sisitsky","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:26.520291+00:00","sources":[{"id":"alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Allogene Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-24T16:17:02.001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e359aa9adfd484ae58d99eb4dfb63c07024ecaf45119a809aaf1295f1b616d75","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:55.528673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:49f57b56db9669a6e5377a23b131b32c4f33cc0d52bccbd255a548a3fddfd7b9","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:56.363968+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7a8e53f8022fc4e59cc536d4294344629256f3aa587b4d4744b940d9713a75d0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALLO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-14T23:19:55.941207+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.841,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.874,"cross_source_agreement":0.75,"temporal_completeness":0.7},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":14,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T04:46:26.520291+00:00","observed_at":"2026-10-16T04:46:26.520291+00:00","reviewed_at":"2026-10-16T04:46:26.520291+00:00","verified_at":"2026-10-16T04:46:26.520291+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/allogene-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}